Robert Blum
speaker
321 appearances
1 recordings
1 series
first heard Feb 2026
last heard 3 Feb
Robert Blum’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Feb 2026 with 1.
Appearances
We
have focused to indications where even with our limited access to capital and with a limited sales and marketing infrastructure, we can build a physician, pharmacy, and patient experience bespoke to this opportunity and our opportunity to lead.
So now to answer your question, over the years,
We have built sales territories configured with sales leaders and managers three, four, five years ago, and a medical affairs team that's harnessing our science.
And as we go to market now,
We have dozens of published peer-reviewed manuscripts that provide support for what our newly hired sales representatives, we call them cardiology account specialists, will be doing.
Those cardiology account specialists were hired in 2025 in two waves.
They were placed into territories.
They were trained so as to be compliant and ready for this moment.
And they're partnered with scientists in their training, medical affairs colleagues in their execution.
And we've built a seamless culture cohesive to all that we know about good science for the benefit of patients and medicine.
The cardiology account specialists have over 20 years on average of sales experience, over 14 years on average of cardiology experience, over five years of President's Awards experience.
And now they're deployed in territories.
And this week, as we go live with product in-channel and REMS program in place, enabling of us to show up for customers in a way that we think will be distinguishing what we do.
And it's not just about promotion.
It's also about digital marketing.
It's also about the patient hub experience bespoke to this opportunity as opposed to retrofitted from prior architecture and execution.
It's about how we've been engaging with payers for several years to be enabling of them to understand what's coming soon and how they can be best prepared for a new medicine.
So all these things have been going on for quite some time, not only in the United States, but also in Europe, where we will be going to market in the second quarter based on our expected hopeful approval in the first quarter.
Yeah, I think your observation is an accurate one.
Showing 61–80 of 321 · page 4 of 17
← Previous
Next →